Ceres Ventures (CEVE) Stock Price & Analysis
CEVE Stock Chart & Stats
- Day’s Range
- $0.04 - $0.04
- 52-Week Range
- $0.04 - $0.04
- Previous Close
- $0.04
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $7,709
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- $101.52K
- Price to Earnings (P/E)
- ―
- Beta
- 118.49
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
CEVE FAQ
What was Ceres Ventures’s price range in the past 12 months?
What is Ceres Ventures’s market cap?
When is Ceres Ventures’s upcoming earnings report date?
Is Ceres Ventures overvalued?
Does Ceres Ventures pay dividends?
What is Ceres Ventures’s EPS estimate?
How many shares outstanding does Ceres Ventures have?
Which hedge fund is a major shareholder of Ceres Ventures?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Ceres Ventures
Ceres Ventures, Inc. is an emerging clean technology firm dedicated to developing and bringing to market innovative environmental solutions aimed at purifying contaminated water, soil, and air. The company's core technological offerings comprise: BluFlow Nanoparticles: A proprietary system that engineers and deploys tailor-made absorbent nanoparticles. These microscopic particles are designed to precisely capture and remove various contaminants and chemicals, and can also be utilized to recover valuable elements and compounds from aquatic environments. BluFlow Advanced Ultrafiltration Technology: An automated ultrafiltration process focused on reclaiming clean water from industrial waste streams and other impure liquid sources. The BluFlow Treatment System, which integrates both the Nanoparticle and Advanced Ultrafiltration technologies. This comprehensive solution effectively eliminates a broad spectrum of pollutants, compounds, and undesirable elements, rendering water sufficiently pure for potential reuse. These solutions find diverse applications, including municipal and industrial water and wastewater purification, remediation of tainted groundwater, and the extraction of valuable resources from various solutions. Previously operating as PhytoMedical Technologies, Inc., the company adopted its current name, Ceres Ventures, Inc., in November 2011. Its headquarters are located in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Frank J. Fabio
- Employees
- 0
- Website
- ceres.ventures
- Address
- 430 Park Avenue, New York City, NY, 10022, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 3 | 4 |
| Technical Analysis | 1 | 1 | 0 |
| Moving Averages | 2 | 2 | 4 |
